Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1997 and is headquartered in San Mateo, California.
Frequently asked questions
What sector does Deltagen Inc (DGEN) operate in?
Deltagen Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Deltagen Inc (DGEN) current stock price?
As of the latest data, Deltagen Inc stock price is $0.00, with a previous close of $0.00.
What is Deltagen Inc (DGEN) current market capitalization?
Deltagen Inc market cap is approximately 2.75 million.
Does Deltagen Inc (DGEN) pay dividends?
No. Deltagen Inc does not pay a dividend.
What is Deltagen Inc (DGEN) beta (volatility) score?
Deltagen Inc has a beta of 68.629, indicating very high volatility compared to the market.